Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer

LIN YANG · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
gastric cancer adenocarcinoma metastatic, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 871545
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.